AKT1 and neoplasm: Mechanistically, miR-107 targets and downregulates the oncogenic protein 14-3-3η, disrupting PI3K/Akt signaling and cell cycle regulation, thereby inhibiting tumor cell proliferation, invasion, and promoting apoptosis.